Evolus, Inc. (EOLS)
7.79
-0.78
(-9.10%)
USD |
NASDAQ |
Sep 10, 13:09
Evolus Market Cap : 514.25M for Sept. 10, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 09, 2026 | 565.74M |
| September 08, 2026 | 586.20M |
| September 04, 2026 | 613.93M |
| September 03, 2026 | 597.42M |
| September 02, 2026 | 598.08M |
| September 01, 2026 | 599.40M |
| August 31, 2026 | 600.06M |
| August 28, 2026 | 586.20M |
| August 27, 2026 | 586.20M |
| August 26, 2026 | 579.60M |
| August 25, 2026 | 592.47M |
| August 24, 2026 | 579.60M |
| August 21, 2026 | 553.85M |
| August 20, 2026 | 551.21M |
| August 19, 2026 | 567.72M |
| August 18, 2026 | 539.99M |
| August 17, 2026 | 512.93M |
| August 14, 2026 | 538.34M |
| August 13, 2026 | 529.43M |
| August 12, 2026 | 536.03M |
| August 11, 2026 | 550.55M |
| August 10, 2026 | 499.72M |
| August 07, 2026 | 501.04M |
| August 06, 2026 | 489.16M |
| August 05, 2026 | 407.96M |
| Date | Value |
|---|---|
| August 04, 2026 | 404.00M |
| August 03, 2026 | 399.38M |
| July 31, 2026 | 384.50M |
| July 30, 2026 | 395.70M |
| July 29, 2026 | 397.01M |
| July 28, 2026 | 409.52M |
| July 27, 2026 | 406.89M |
| July 24, 2026 | 393.72M |
| July 23, 2026 | 394.38M |
| July 22, 2026 | 387.80M |
| July 21, 2026 | 382.20M |
| July 20, 2026 | 365.08M |
| July 17, 2026 | 377.26M |
| July 16, 2026 | 370.68M |
| July 15, 2026 | 392.41M |
| July 14, 2026 | 412.82M |
| July 13, 2026 | 429.28M |
| July 10, 2026 | 435.20M |
| July 09, 2026 | 451.00M |
| July 08, 2026 | 447.05M |
| July 07, 2026 | 456.93M |
| July 06, 2026 | 460.22M |
| July 02, 2026 | 454.29M |
| July 01, 2026 | 443.76M |
| June 30, 2026 | 456.93M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ANI Pharmaceuticals, Inc. | 1.619B |
| Corcept Therapeutics, Inc. | 12.46B |
| Veru, Inc. | 42.80M |
| Johnson & Johnson | 641.82B |
| Eli Lilly & Co. | 1.061T |
Market Cap Related Metrics
| PS Ratio | 1.607 |
| Price | 7.79 |
| Earnings Yield | -6.77% |